Biodesix (BDSX) Debt to Equity: 2019-2025
Historic Debt to Equity for Biodesix (BDSX) over the last 5 years, with Sep 2025 value amounting to -$27.36.
- Biodesix's Debt to Equity fell 2210.43% to -$27.36 in Q3 2025 from the same period last year, while for Sep 2025 it was -$27.36, marking a year-over-year decrease of 2210.43%. This contributed to the annual value of $1.74 for FY2024, which is 86.01% down from last year.
- Latest data reveals that Biodesix reported Debt to Equity of -$27.36 as of Q3 2025, which was down 166.55% from $41.11 recorded in Q2 2025.
- In the past 5 years, Biodesix's Debt to Equity registered a high of $41.11 during Q2 2025, and its lowest value of -$30.61 during Q3 2023.
- Over the past 3 years, Biodesix's median Debt to Equity value was $1.30 (recorded in 2024), while the average stood at -$0.40.
- Its Debt to Equity has fluctuated over the past 5 years, first spiked by 4,080.49% in 2021, then slumped by 2,210.43% in 2025.
- Quarterly analysis of 5 years shows Biodesix's Debt to Equity stood at $1.41 in 2021, then increased by 21.91% to $1.72 in 2022, then skyrocketed by 626.61% to $12.46 in 2023, then plummeted by 86.01% to $1.74 in 2024, then crashed by 2,210.43% to -$27.36 in 2025.
- Its Debt to Equity was -$27.36 in Q3 2025, compared to $41.11 in Q2 2025 and $3.32 in Q1 2025.